AU741137B2 - Covered expanding mesh stent - Google Patents

Description

-1I- *e V. 9*

S.

S

C

C. C.

S

S

PC..

C.

C

S

AUSTRALIA

PATENTS ACT 1990 DIVISIONAL APPLICATION NAME OF APPLICANT: Menlo Care, Inc.

ADDRESS FOR SERVICE: DAVIES COLLISON CAVE Patent Attorneys 1 Little Collins Street Melbourne, 3000.

INVENTION TITLE: COVERED EXPANDING MESH STENT The following statement is a full description of this invention, including the best method of performing it known to us: Q:\OPER\AYD\2279710.DIV 31/3/0 -1A- COVERED EXPANDING MESH STENT BACKGROUND OF THE INVENTION 1. FIELD OF THE INVENTION: This invention relates generally to the field of stents for use primarily in ducts and vessels of the body, and more particularly, to the area of expandable stents which expand and/or reconform after implantation in the body.

2. ART BACKGROUND: A number of biomedical devices have been used for the stenting of body passages that have become blocked or are otherwise damaged, or weakened. Expanding stents seem the most promising for this purpose because of the advantages provided by insertion of a small diameter tube-like device and the ultimate enlargement of the diameter to accommodate the flow of body fluids or food and the increase in time prior to occlusion of the stent.

00.: There are a number of different types of devices for stenting of body passages that may be classified into two general categories: namely, expandable meshes which includes self-expanding types and non-self-expanding types, and non-expandable stents which are typically made of plastic or polymeric material. The self-expanding meshes can be made of a material, such as Nitinol, which changes configuration upon heating to body temperature. Other self-expanding meshes are made of resilient mesh material which can be flexed down into a small diameter tube and held in place in such a configuration until it is released, at which time it expands to a larger diameter configuration.

The non-self-expanding meshes are expanded by use of an inflatable balloon which is placed inside the mesh in a small diameter configuration, and then inflated, thereby expanding the mesh to a larger -2diameter configuration. The balloon is then deflated for removal, leaving the mesh in its expanded configuration.

The expandable metal mesh stents are particularly advantageous in that they can increase in size up to 36 Fr. However, the metal meshes are difficult to remove since tissue in-growth occurs over time. A number of other problems, for example, mucosal hyperplasia, fungal proliferation, or neoplasm also are common with expandable metal mesh stents.

The expandable mesh stents can be made in a variety of materials such as, for example, stainless steel. The expandable mesh stents can be made in a variety of configurations such as a coiled spring, a variety of zig-zag patterns including various stents'knows as stents, braided filament, and other collapsible configurations. One type of expandable stent comprises a cylindrical member having a slit cut along its length, so that the edges along the length can overlap to allow for compression to a reduced size. A further configuration which may be described as a perforated tube comprises a generally rigid tube with openings cut therein to allow for radial expansion under force of an expansion balloon or by expansion due to heating. The expandable mesh stents can be braided, woven, knitted, formed, molded, machined or made by other methods known in the art. Various mesh designs are disclosed, for example, in U.S. Patent Nos. 4,512,338, 4,503,569, 4,922,905, 4,733,665, 4,950,227, 5,089,006 and 5,061,275. Other materials, configurations and methods of manufacture in addition to those described above are known.

As used herein, the term "expandable stent body" is meant to include without limitation, self-expanding and non-self-expanding configurations made of any generally rigid or springy material which when expanded have an open network or arrangement which would otherwise allow tissue in-growth, and would not otherwise prevent fluid flow through its walls. Several of these prior art mesh stents have been utilized with a polymeric sheath or cover; however, since these sheaths must be stretched to increase in size, they exert a force that resists expansion, which tends to limit the final expanded size of the mesh. Additionally, this resistance may make expansion more problematic. Alternatively.

the sheath may be folded or bundled over the mesh when it is compressed, so that no force is exerted upon expansion. However, this method increases the size of the compressed stent, so that a larger size catheter is required for a given size stent.

The plastic or polymeric stents exist only in smaller sizes because of the difficulty of inserting a larger catheter through the channel of Sexisting scopes or in narrow body passages, such as veins or arteries, 0 bile ducts, the esophagus, prostate, and the like. A disadvantage of the plastic stents is that as a result of the smaller size of the lumen, the .e plastic stents occlude faster than the expandable stents. One advantage of plastic or polymeric stents is that their closed structure prevents tissue in-growth which therefore makes it easier to remove, and less likely to be occluded by tissue in-growth from the outside.

Some plastic or polymeric stents,.as mentioned above, are simply small tubes.

With the current self-expandable mesh stents, the tubular body may comprise a flexible material where the diameter can be changed between a small diameter for insertion, and a final, expanded diameter after placement allowing for fluid flow therethrough. In some cases the self-expanding device assumes its final, expanded configuration when in an unrestricted condition, free of external forces in the radial direction.

These type of devices must be compressed and loaded into a sheath that restrains the device radially for insertion into the body via a catheter.

After insertion, the sheath or loading system may be removed to allow for expansion. After removal of the sheath, the device expands to its final diameter under spring-like forces resulting from the compression.

In the case of heat sensitive materials, the stent takes on its expanded shape after it is heated above its transition temperature. With non-selfexpanding mesh stents, upon expansion by the use of, for example, an P:\OPER\Axd22797 IO.doc-24/(J) I -4expansion balloon the final expanded configuration is achieved. Additionally, other methods of expansion and contraction are known.

What is needed is an expandable stent that allows for easy insertion and that increases in size to increase the time for occlusion to occur. The expandable stent should eliminate or minimize tissue in-growth without requiring a covering which either resists expansion or which must be folded or bundled when the stent is in the small radius, non-expanded condition. Further, it is desirable in some situations that the expandable stent does not require a loading sheath, so that a smaller sized catheter can be used to insert the stent into the body.

SUMMARY OF THE INVENTION S: According to the present invention, there is provided a stent for insertion into the 15 interior of a body comprising: an expandable stent body, said expandable stent body having a first i configuration having a first diameter and a second configuration having a second diameter wherein said first diameter is less than said second diameter; and, an expandable polymer layer coupled with said expandable stent body, 20 wherein said expandable polymer layer inhibits tissue ingrowth through walls of said stent, said expandable polymer layer having a third configuration having a third diameter and a fourth configuration having a fourth diameter, said fourth Sdiameter being greater than said third diameter, wherein said expandable polymer layer is moveable between said third configuration and said fourth configuration without significant resistance and is moveable between said fourth configuration and said third configuration without folding or bunching.

The present invention advantageously comprises an expandable stent body with an expandable polymer layer which can be on the inside of the expandable stent body, on the outside of the expandable stent body, within the interstices of the expandable stent body, or any combination of inside, outside and within the interstices of the stent body. The expandable polymer layer advantageously does require either stretching or folding, nor does it exert a significant resistance to sbI epansion.

OFRC

P:\OPER\Axd\2279710 doc-24/091I -4A- The present invention may advantageously be used in a number of different fields of medicine: products may include expandable biliary, vascular, endotracheal, esophageal, and prostatic devices. The size and design may be different for each medical application.

In one embodiment of the present invention, the polymer is expandable by hydration. For example, the polymer may be a member of the family of polymers sold under the trademarked name AQUAVENE®, examples of which are described in U.S. Patent Nos. 4,883,699 and 4,911,691. Other expandable polymers which expand by hydration known in the art include HYPAN® (Hydrolyzed polyacrylonitrile) Patent No. 4,480,642), hydrophilic polyether polyurethane Patent No. 4,798,876), polyurethane diacrylate (U.S.

*ooo P:\OPER\AXD\49296-96.SPE 2/2,00 Patent No. 4,424,305), and various hydrogels, including cross-linked PVP (polyvinyl pyrrolidone), PVA (polyvinyl alcohol), PEO (polyethylene oxide) and pHEMA (poly (hydroxyethyl methacrylate)).

The hydrophilic polymer AQUAVENE comprises a combination of a nonhydrophilic component an elastomer such as urethane, silicone, PVC or the like) and a hydrophilic component (a hydrogel) which allows the material to swell and increase in size and maintain strength as outlined, for example, in U.S. Patent No.

4,883,699. In a preferred embodiment the amount of expansion of the polymer layer is approximately equivalent to the amount of expansion of the stent body in the expanded condition. The amount of expansion of a material or device may be described by the expansion ratio. For the stent body, this may be the ratio of, for example, the diameter in the compressed condition to the diameter in the unrestricted, expanded condition. For the polymer layer, the expansion ratio may be the ratio of the diameter in the non-hydrated state to the diameter in the fully hydrated state. In the case of AQUAVENE, the ratio of hydrophilic to non-hydrophilic component controls the amount of expansion of the material upon hydration, so that the amount of polymer expansion can be matched with the amount of expansion of the stent body. Under a currently preferred embodiment of the present invention, the elastomer content should generally be in the range of approximately 15-75%, and preferably 20-65%, and more preferably 25-30% by volume in the dry (non-hydrated) state.

In an alternative embodiment of the present invention, the polymer layer comprises a material which, by virtue of its method of manufacture, or, e.g., arrangement of the knit, may expand between a first, smaller configuration and a second, larger configuration without requiring stretching of the material to the larger configuration, so that the polymer layer can be expanded without offering significant resistance. Further, the material does not require folding or bunching to be placed in the smaller configuration, so that the presence of the material does not significantly increase the size of the compressed stent or reduce the size of the lumen.

One advantage of the present invention is the elimination of the open mesh of P:\OPER\AXD\492%-96.SPE 212/00 -6the prior art. The closed smooth surface of the polymer prevents tissue and tumor ingrowth and allows for easier removal of the prosthesis. It is recognized that there has been some use in the field of expandable meshes combined with polymeric materials which must stretch to expand as described earlier. However, in accordance with one embodiment of the present invention, the polymeric materials also self-expand, and can be devised to expand approximately the same degree as the open stent body. In accordance with a further embodiment, the polymer layer can change from a small configuration to a larger configuration without significant resistance. Thus, unlike prior art devices which either do not have any polymer layer, or which have a polymer layer 1 0 which stretches with some resistance, the present invention allows for expansion of the stent body with no substantial resistance. It will be recognized however, that even if there is a small amount of resistance by the polymer layer, it may be within the spirit and scope of the present invention.

An advantage of the present invention relative to the use of the above described self-expandable polymer layers alone is that the expandable stent body provides a resistance to crushing which is much greater than the resistance to crushing of the polymer layer alone if the polymer formulation were such that it would expand as much ol i as the stent body. The structure of polymeric stents of self-expandable polymer which resist crushing may require excessively thick walls, which would either defeat the purpose of attempting to make the outside diameter as small as possible for easy insertion, or alternatively, make the internal diameter very small thereby defeating the purpose of using the stent to allow a larger volume of fluid to pass through the duct.

The expandable stent body of the present invention advantageously provides the mechanical strength necessary to prevent occlusion due to lateral forces such as from tumor growth.

Another advantage of the present invention is the ability to load additives into the hydrophilic polymer layer which may be released at a controlled rate. The additives may include, for example, antibacterial, anti-microbial, anti-calcification, growth hormones, anti-cancer-related drugs, anti-thrombogenic agents, and antirestenosis agents which are beneficial in conjunction with, or in addition to the P:'.OPER\AXD\49296-96.SPE 2i2,0 -7implantation of the stent.

In addition, the present invention still has the advantage of the expandable meshes which allow for the implantation of smaller prosthesis which thereafter increase in lumen size after insertion for greater flow rate, and longer implantation time prior to occlusion.

The design of the expandable stent body may consist of any type of selfexpanding meshes such as those described in the above-mentioned patents. The stent body may be a self-expandable mesh capable of collapsing to a smaller diameter ".and expanding if it is not held radially by a sheath, or in the case of heat-sensitive materials, until the temperature rises above the transition temperature of the material.

In some embodiments, the expandable stent body may also be a mesh of the non-self expanding type which requires a separate force, typically an expansion balloon, to cause the expansion.

In an embodiment of the invention, the expandable hydrophilic polymer layer holds the expanding stent body until the hydrophilic component of the polymer hydrates inside the body. The polymer after hydration softens, swells, and expands to allow the contracted stent body to expand. In alternative embodiments, some expandable configurations of non-hydrophilic polymers have a structure such that they can change between a small to a large configuration without significant resistance and without folding or bunching in the small configuration. Under such circumstances, these polymers can be expanded along with the expandable stent body, either under the force of expansion from the stent body and/or under pressure from an expansion balloon.

BRIEF DESCRIPTION OF THE DRAWINGS Embodiments of the invention will now be described in detail with reference to the accompanying drawings in which: Figure 1 is a sectional view of an embodiment of the present invention in collapsed condition.

Figure 2 is a sectional view of the embodiment of the present invention of Figure 1 in an expanded condition.

Figure 3 is a perspective view of the embodiment of the present invention of Figure 1 and 2.

Figure 4 is a perspective view of a further embodiment of the present invention.

Figure 5 is a perspective view of a further embodiment of the present invention.

Figure 6 is a view of a sectional view of a further embodiment of the present invention.

Figure 7 is a view of a portion of the embodiment of Figure 6.

DETAILED DESCRIPTION OF THE INVENTION The present invention comprises a stent or other medical generally tube-like device for implantation in the body on a temporary, semipermanent or permanent basis, the invention comprising an expandable stent body or mesh with an expandable polymer layer on the inside of the stent body, on the outside of the stent body, within the interstices of the stent body or any combination thereof.

As shown in Figure 1, an embodiment of the present invention comprises a tubular shaped stent 10 comprising a mesh 12 and an outer layer 14. In the embodiment shown in Figure 1, the outer layer 14 covers all or most of the outer surface of mesh 12. However, the layer 14 is shown only at the top and bottom edges of the Figure for purposes of illustration to allow viewing of mesh 12. In general, outer layer 14 is a sheath-like structure which may be attached to the mesh 12 in a variety of ways as discussed later. A retention flange 16, or other mechanism, such as exposed wires, may be provided, to assist in maintaining the positioning of the structure after placement in the body, as is known in the prior art. Figure 1 shows the stent in a collapsed position which is useful for initial insertion of the stent into the body.

Referring to Figure 2, the present invention 10 is now shown in its expanded condition. It still comprises mesh 12 and an outer layer 14, again shown only at the top and bottom edges of Figure 2 for purposes of illustration. In the condition shown in Figure 2, the stent 10 may have been inserted into a duct in the body from which outer layer 14 has absorbed water and expanded. The outer layer 14 upon expansion, no longer holds mesh 12 in the collapsed position, so that it too expands to the configuration shown in Figure 2.

Figure 3 shows expanded stent 10 in perspective view. As can be seen, the mesh 12 is substantially completely covered by outer layer 14.

Figure 4 shows an alternative embodiment of the present invention. As shown, stent 40 comprises mesh 42 and inner layer 44.

Inner layer 44 is similar to layer 14 of Figures 1-3, with the exception that it is disposed within the mesh 42. Again, the stent 40 may have retention flange 46, or similar mechanism.

Figure 5 shows a further alternative embodiment of the present invention. In Figure 5, stent'50 comprises mesh 52, outer layer 54a and inner layer 54b. A portion of outer layer 54a is cut-away for purposes of illustration for viewing of mesh 52, and inner layer 54b within mesh 52. The outer and inner layers 54a and 54b are similar to layer 44 of Figure 4, and layer 14 of Figures 1-3.

Figure 6 shows a sectional view of stent 60. In this embodiment, stent 60 comprises a mesh 62 with polymer 64 disposed within the interstices of mesh 62. Although not shown, stent 60 may have a retention flange or other means to hold the stent in place within the body. The polymer 64 is similar to the layers 54, 44 and 14 of the previous embodiments, with the exception, instead of being sheath-like as in layers 14 and 54a, or liner-like as in layers 44 and 54b, the layer 64 is now disposed within the interstices of mesh 62. Typically, an interstitial layer is formed in conjunction with an inner layer, an outer layer, or both. Figure 7 shows a portion of the stent 60 of Figure 6.

A number of materials may be used for the expandable stent body such as stainless steel, tantalum, gold, titanium, nitinol heat sensitive material, or any suitable plastic material that may be formed so it may be collapsed, and when released, expand radially.

The expandable stent body may be self-expanding. Alternatively, the stent body may not be self-expanding, which would require external, or more typically, internal assistance, usually in the form of an expansion balloon. The stent body may be any configuration and may be made in any manner, such as is disclosed in the earlier cited patents.

The polymer layers, such as layers 14, 44, 54a, 54b and 64 of the present invention may be one of the earlier described hydrophilic polymers, which expand upon hydration. Alternatively, these layers may :oooi be made of a material which expands from a first, smaller configuration to a second, larger configuration, without requiring stretching and without exerting significant force against expansion. Further, the material does not require folding or bunching to contract from the expanded, larger configuration to the smaller configuration. One material which has this property is expanded polytetrafluoroethylene (PTFE). Typically, expanded PTFE is fabricated by pulling or expanding the PTFE after extrusion so that the PTFE is expanded in a longitudinal direction. The expanded PTFE has the above-described property of being capable of being "pushed" and "pulled" between a shorter and longer length, without requiring stretching, or exerting significant resistance against expansion when going from the shorter to the longer -11length, and without requiring folding or bunching of the PTFE when being pushed into the shorter length from the longer length.

In the present invention, since it is desirable for the polymer layer to expand radially after insertion into the body, the PTFE may be radially expanded after extrusion. The radially expanded PTFE may be used, for example, as the layer 14 of Figures 1 and 2. The PTFE layer 14 may be placed on the mesh 12 in the configuration shown in Figure 1, without requiring folding or bunching of the material 14, and then expand to the configuration shown in Figure 2, without offering significant resistance, and without limiting the final expanded diameter.

As an alternative to radially expanded PTFE, longitudinally expanded PTFE may be used provided it is disposed on the mesh 12 such that its S•direction of expansion is radial. For example, a length of longitudinally expanded PTFE may be cut and wrapped around an expandable mesh 12 with the longitudinal direction perpendicular to the length of the mesh. The expanded PTFE may be desirable in comparison to a hydrophilic polymer layer when mesh 12 is non-self-expanding, since the mesh 12 can be expanded by an expansion balloon, without any significant resistance from the polymer layer during expansion. In contrast, in using a non-self-expanding mesh in combination with a hydrophilic polymer layer, it would be necessary to wait until hydration of the hydrophilic polymer prior to expansion.

In addition to expanded PTFE described above, other polymers, such as, for example, dacron may be used in the present invention. If the polymer is not expanded as with PTFE, the structure of the material should be such that the material has the above-described ability to assume a small, compressed configuration and a larger expanded configuration, without requiring stretching to the larger configuration, and without requiring folding to the smaller configuration. The material may have this property by virtue of a weave or structure in which the fibers or filaments of the material are not aligned substantially longitudinally in the direction of expansion. In this way the material has some range of movement where the fibers or filaments of the material -12move in an accordion or bellows-like fashion. While, on a small scale the fibers or filaments of the material may fold in on themselves upon compression, it should be noted that no large scale folding or bunching of the material occurs, so that the compression to the small size does not significantly increase the required size of the catheter. With regard to this embodiment of the invention, the expansion ratio of the material may be described as, for example, the ratio of the expanded diameter to the compressed diameter, where the compressed diameter is the diameter at which the material is compressed to its smallest size without requiring folding or bunching on a large scale, and the expanded diameter is the diameter when the material has been expanded as far as possible without stretching. It will be appreciated that a material such as expanded PTFE, or other materials as described herein, may expand beyond this, but stretching would be required.

A preferred material to use for holding the mesh in a collapsed position, until insertion in the body where it allows the mesh to expand, is a hydrophilic polymer such as that sold under the tradename SAQUAVENE®. An AQUAVENE® polymer is a co-continuous blend of a '•non-hydrophilic polymer (elastomer) and a hydrophilic polymer (hydrogel). In a preferred embodiment, the hydrophilic component is S* generally in the range of approximately 15-75%, preferably 20-65% and more preferably 25-30%, by volume in the dry (non-hydrated) state.

Some amount of the non-hydrophilic component is desirable to provide some physical integrity of the polymer sufficient for the purposes of the present invention. However, a cross-linked hydrogel alone can be used.

It should be noted that although, as described earlier, the stent body provides a greater crush resistance than a hydrophilic polymer layer of the same expansion ratio, the hydrophilic polymer layer provides some crush resistance, so that the present invention provides enhanced crush resistance as compared with either the stent body alone or the polymer layer alone.

The stent of the present invention may be formed by a number of different techniques in a number of different configurations. For P:OPER\AXD\49296-96.SPE 2/2A -13 example, a hydrophilic polymer layer, in the form of a sheath, may be bonded to the expandable stent body in its collapsed position so that the "dry" polymer holds the expandable stent body in a collapsed state. Alternatively, the polymer may be laminated, embedded, coated, extruded, incorporated or molded around the expandable stent body in its collapsed condition. Upon hydration inside the body, the polymer layer expands and loses its ability to restrain the expandable stent body, allowing the stent body to expand radially. In some cases, it may be necessary to allow the polymer layer to move relative to the expandable stent body. For example, it may be desirable to use a polymer layer in the form of a sheath placed external and/or internal to the expandable stent body which is not bonded to or embedded within the stent body, so that the polymer layer does not bind the stent body, for .jexample the filaments of a mesh, thereby preventing it from fully expanding. In many cases, however, the polymer layer may be so bonded or embedded, as the polymer S' in the hydrated state allows for sufficient movement of the stent body, for example the *o filaments of a mesh to allow it to self expand. The polymer layer of an embodiment using expanded PTFE or similar material may be coupled to the stent body using the S0., above techniques. However, this type of polymer by itself will not hold the stent body in the collapsed configuration.

In the present invention, the expandable polymer layer or layers are designed such that they have an approximately equal expansion ratio as the expandable stent body. In this way, the expandable polymer layer does not in any way resist the expansion of the expandable stent body, allowing for full expansion of the stent body.

It will be appreciated that there may be a slight mismatch in expansion ratios without significantly affecting the performance of the device. Further, if desired, the expansion ratio of the hydrophilic polymer layer may be provided such that it assists in the expansion of the stent body. For example, the hydrophilic polymer layer may have a slightly greater expansion ratio, which may enable some stent bodies to expand to a slightly larger size than the stent body would expand without the presence of the hydrophilic polymer layer.

As described above, the polymer layer may be placed externally, internally P:'OPER\AXD\49296-96.SPE 2?2100 -14within the interstices of the stent body, or any combination thereof. Typically, the placement of polymer layers interstitially may be achieved in conjunction with an external or internal layer. One preferred embodiment is to form the polymer layer both internal and external to the stent body in its collapsed position, so that the stent has a smooth inner lumen and a smooth outer surface. The smooth outer surface allows for easier removal of the stent, while a smooth inner surface may be helpful in increasing the time until occlusion occurs. In embodiments using a hydrophilic polymer layer, the polymer layer may expand through the stent body to some extent, so that a single polymer layer either internal or external, may provide a smooth surface both 10 internal and external of the stent body. Further, an advantage of embodiments using a hydrophilic polymer which forms hydrogel is that the hydrogel is typically highly :biocompatible.

aI The existing self-expanding meshes must be pre-loaded in a sheath delivery system, which holds the mesh in a tight configuration. The present invention may eliminate the need for a sheath in some cases, since the hydrophilic polymer layer of the present invention restricts the stent body in a collapsed position until after insertion and until the polymer layer is sufficiently hydrated. This arrangement can allow for a S• smaller external diameter delivery system than if a sheath if necessary, because the additional diameter of the sheath becomes unnecessary since its function is undertaken by the polymer layer. In some cases, if the polymer layer hydrates too quickly a sheath may be necessary to allow placement of the stent prior to hydration.

Alternatively, if desired, a coating could be applied to the polymer layer to slow down the hydration. The coating may be similar to a material used to make time release drugs, or absorbable sutures. The coating may be designed to take any desired predetermined amount of time to dissolve, to allow for any desired amount of time in which to place and manoeuvre the stent in the body. For examples of the suitable materials, see, for example, P OPER'AXD 49296-t% SPE 2 2.00 Barrows, Thomas "Syntlhetic Bioabsorbable Polymers", in High Performance Biomaterials. M. Szycher, ed. 1991, pp. 243 257.

As described above, the polymer layer may be a hydrophilic polymer, or may be an expandable polymer that expands without stretching, such as expanded PTFE.

Additionally, the layer may be internal, and/or external, and/or interstitial. It will be appreciated that in an embodiment having more than a single layer, one or more of the layers may be a hydrophilic polymer and one or more of the layers may be a material such as expanded PTFE, if desired. Such an embodiment may be useful for delaying 1 0 hydration for some period, so that the stent may be placed. For example, one or more hydrophilic layers may be disposed internal, and/or external, and/or interstitial of the stent body. An expanded PTFE layer, for example, may then be placed internal and/or o• external to any hydrophilic polymer layers to delay hydration.

1i 15 The above present invention may be used in a number of different fields of medicine: products may include expandable biliary, vascular, endotracheal, esophageal, and prostatic devices. The size and design may be different for each medical application.

20 Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", and variations such as "comprises" and "comprising", will be understood to imply the inclusion of a stated integer or group of integers or steps but not the exclusion of any other integer or group of integers or steps.

The reference to any prior art in this specification is not, and should not be taken as, an acknowledgment or any form of suggestion that that prior art forms part of the common general knowledge in Australia.

It will be obvious to a person of ordinary skill in the art that numerous modifications and changes can be made to the above apparatus in order to /S7-\saccomplish the same function without departing from the spirit and scope of the resent invention.

Claims (9)

1. A stent for insertion into the interior of a body comprising: an expandable stent body, said expandable stent body having a first configuration having a first diameter and a second configuration having a second diameter wherein said first diameter is less than said second diameter; and, an expandable polymer layer coupled with said expandable stent body, wherein said expandable polymer layer inhibits tissue ingrowth through walls of said 0: 0 stent, said expandable polymer layer having a third configuration having a third diameter and a fourth configuration having a fourth diameter, said fourth diameter being greater than said third diameter, wherein said expandable polymer layer is moveable between said third configuration and said fourth configuration without S. significant resistance and is moveable between said fourth configuration and said third configuration without folding or bunching. 15

2. The stent as described in claim 1 wherein said expandable polymer layer ;o ~comprises expanded PTFE. S:

3. The stent of claim 1 wherein said expandable stent body is self-expanding. 20

4. The stent of claim 1 wherein said expandable stent body comprises a material selected from the group consisting of stainless steel, tantalum, gold, titanium, nitinol, and plastic.

The stent of claim 1 wherein said expandable stent body has a configuration selected from the group consisting of coiled spring, braided filament, perforated tube, slit tube, and zig-zag.

6. The stent of claim 1 wherein polymer is disposed on the inside of said stent body, the outside of said stent body, the interstices of said stent body or any cS U bination thereof.

OFF\ The stent of claim 1 wherein said expandable stent body has a first expansion (C P:\OPER\Axd\22797 O.doc24/09/ -17- ratio and said polymer has a second expansion ratio, wherein said first and said second expansion ratio are approximately equal.

8. The stent of claim 1 wherein said expandable polymer layer inhibits liquid flow through walls of said stent.

9. A stent according to claim 1 and substantially as hereinbefore described with reference to the drawings. DATED this 24 th Day of September, 2001 Menlo Care, Inc. by its Patent Attorneys i 15 DAVIES COLLISON CAVE *i